| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/07/2011 | US20110082283 Multimeric elp fusion constructs |
| 04/07/2011 | US20110082208 Therapies for cancer using isotopically substituted lysine |
| 04/07/2011 | US20110082190 Nucleic Acids Encoding Anti-IL-12 Antibody |
| 04/07/2011 | US20110082189 Use of compounds activating sirt-3 for mimicking exercise |
| 04/07/2011 | US20110082185 Cancer-testis gene silencing agents and uses thereof |
| 04/07/2011 | US20110082158 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same |
| 04/07/2011 | US20110082152 Therapeutic agents useful for treating pain |
| 04/07/2011 | US20110082134 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 04/07/2011 | US20110082106 Methods of activating nkt cells |
| 04/07/2011 | US20110082100 Therapeutic substances that modulate genome methylation |
| 04/07/2011 | US20110082096 Gene and pathway and their use in methods and compositions for predicting onset or progression of autoimmune and/or autoinflammatory diseases |
| 04/07/2011 | US20110082095 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| 04/07/2011 | US20110082093 Methods and compositions for treating trinucleotide repeat disorders |
| 04/07/2011 | US20110082092 Interfering rna delivery system and uses thereof |
| 04/07/2011 | US20110082090 Compounds suited as nanocarriers for active agents and their use |
| 04/07/2011 | US20110082078 Methods and compositions for treating neuropathies |
| 04/07/2011 | US20110082073 Modified Cpn10 and PRR signalling |
| 04/07/2011 | US20110082038 Eukaryotic translation initiation factor gene regulatory elements for use in plants |
| 04/07/2011 | US20110081722 Animal protein-free media for cultivation of cells |
| 04/07/2011 | US20110081721 Process for producing a tissue transplant construct for reconstructing a human or animal organ |
| 04/07/2011 | US20110081720 Method of differentiating stem cells into cells of the endoderm and pancreatic lineage |
| 04/07/2011 | US20110081719 Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same |
| 04/07/2011 | US20110081703 Chimeric isoprenoid synthases and uses thereof |
| 04/07/2011 | US20110081696 Polypeptides Having Cellobiohydrolase II Activity and Polynucleotides Encoding Same |
| 04/07/2011 | US20110081678 Method for producing beta-alanyl-amino acid or derivative thereof |
| 04/07/2011 | US20110081674 Continuous-flow deformability-based cell separation |
| 04/07/2011 | US20110081664 Multipurpose microfluidic device for mimicking a microenvironment within a tumor |
| 04/07/2011 | US20110081661 Modified photoproteins with increased affinity for calcium and enhanced bioluminescence and uses thereof |
| 04/07/2011 | US20110081658 T1r3 binding assays |
| 04/07/2011 | US20110081656 Secreted proteins and uses thereof |
| 04/07/2011 | US20110081644 Cell line stably expressing mutated oncoprotein e6 and method of screening anticancer compound of uterine cervical cancer using the same |
| 04/07/2011 | US20110081642 Selection of B Cells with Specificity of Interest: Method of Preparation and Use |
| 04/07/2011 | US20110081398 Multi-mechanism surgical compositions |
| 04/07/2011 | US20110081395 Ultra-nanocrystalline diamond as a biomaterial for enhancing proliferation and differentiation of neural stem cells |
| 04/07/2011 | US20110081381 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/07/2011 | US20110081369 Immune modulation with death receptor-induced apoptosis |
| 04/07/2011 | US20110081363 Compositions and methods for biological sample storage |
| 04/07/2011 | US20110081361 Antibodies that bind interleukin-4 receptor |
| 04/07/2011 | US20110081355 Methods of Diagnosing and Treating Conditions Using Anti-IL-6 Antibodies |
| 04/07/2011 | US20110081352 Immunogenic peptides and methods of use for treating and preventing cancer |
| 04/07/2011 | US20110081346 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS |
| 04/07/2011 | US20110081344 Soluble zcytor 11 cytokine receptors |
| 04/07/2011 | US20110081343 Vaccines directed to langerhans cells |
| 04/07/2011 | US20110081327 Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection |
| 04/07/2011 | US20110081326 Differentiation of mesenchymal stem cells into fibroblasts, compositions comprising mesenchymal stem cell-derived fibroblasts, and methods of using the same |
| 04/07/2011 | US20110081325 Novel treatment of heart diseases |
| 04/07/2011 | US20110081321 Omentum as a source of stromal/stem cells and medical treatments using stromal/stem cells |
| 04/07/2011 | US20110081317 Enhancing Gene Transfer |
| 04/07/2011 | US20110081315 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 04/07/2011 | US20110081312 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 04/07/2011 | US20110081311 Complexes of il-15 and il-15ralpha and uses thereof |
| 04/07/2011 | US20110078946 Compositions and methods for promoting fatty acid production in plants |
| 04/07/2011 | CA2781520A1 Mammary artery derived cells and methods of use in tissue repair and regeneration |
| 04/07/2011 | CA2776778A1 Peptides |
| 04/07/2011 | CA2776271A1 Anti-hsv antibody |
| 04/07/2011 | CA2776143A1 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
| 04/07/2011 | CA2775846A1 T-cell receptor capable of recognising an antigen from cytomegalovirus |
| 04/07/2011 | CA2775685A1 Monoclonal antibody against human hig-1 polypeptide |
| 04/07/2011 | CA2775582A1 Insecticidal proteins |
| 04/07/2011 | CA2772248A1 Methods and kits for cell release |
| 04/06/2011 | EP2306174A2 Apparatus and methods for providing sex-sorted animal sperm |
| 04/06/2011 | EP2306173A2 Apparatus and methods for providing sex-sorted animal sperm |
| 04/06/2011 | EP2305832A2 Apparatus and methods for providing sex-sorted animal sperm |
| 04/06/2011 | EP2305827A1 Cancer antigen MAGE-A9 and uses thereof |
| 04/06/2011 | EP2305825A1 Method of vitamin production |
| 04/06/2011 | EP2305824A1 Multiple inducible gene regulation system |
| 04/06/2011 | EP2305823A1 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 04/06/2011 | EP2305820A1 Xylanases, nucleic acids encoding them and methods for making and using them |
| 04/06/2011 | EP2305817A2 Anti-IL-12 antibodies, compositions, methods and uses |
| 04/06/2011 | EP2305816A1 Mutation in the Parkin gene, compositions, methods and uses |
| 04/06/2011 | EP2305803A1 Thermostable 1,5-anhydroglucitol dehydrogenase, and method for measurement of 1,5-anhydroglucitol by using the same |
| 04/06/2011 | EP2305802A1 Modified vitamin K-dependent polypeptides |
| 04/06/2011 | EP2305796A1 Process for producing cytotoxic lymphocytes |
| 04/06/2011 | EP2305795A1 Method of collecting placental stem cells |
| 04/06/2011 | EP2305794A1 Expansion of renewable stem cell populations |
| 04/06/2011 | EP2305793A1 Process for producing cytotoxic lymphocytes |
| 04/06/2011 | EP2305715A2 Monoclonal antibody to osteoprotegerin binding protein |
| 04/06/2011 | EP2305714A2 Anti-interferon-alpha subtypes antibodies |
| 04/06/2011 | EP2305713A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305712A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305710A2 Synthetic antibody phage libraries |
| 04/06/2011 | EP2305709A1 Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods for use thereof |
| 04/06/2011 | EP2305299A1 Chimeric alphavirus replicon particles |
| 04/06/2011 | EP2305277A1 Use of tolerogenic dendritic cells in treatment and prevention of atherosclerosis |
| 04/06/2011 | EP2305276A2 Processed lipoaspirate cells for use in therapy |
| 04/06/2011 | EP2305242A2 20-carboxy-(S)-trioxilin A3 for treating neurologic disorders |
| 04/06/2011 | EP2305173A2 Apparatus and methods for providing sex-sorted animal sperm |
| 04/06/2011 | EP2305172A2 Apparatus and methods for providing sex-sorted animal sperm |
| 04/06/2011 | EP2305171A2 Apparatus and methods for providing sex-sorted animal sperm |
| 04/06/2011 | EP2305027A2 Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
| 04/06/2011 | EP2304408A2 Method for and material of a shape standard |
| 04/06/2011 | EP2304036A2 Methods and means of increasing the water use efficiency of plants |
| 04/06/2011 | EP2304035A2 Fusion protein and use thereof |
| 04/06/2011 | EP2304030A1 Recombinant dna constructs and methods for modulating expression of a target gene |
| 04/06/2011 | EP2304029A1 Surface display of whole antibodies in eukaryotes |
| 04/06/2011 | EP2304023A2 Platelet fraction deriving from placental blood |
| 04/06/2011 | EP2304022A1 THE USE OF EXTRACT OF SELENIUM ENRICHED YEAST (Se-YE) IN MAMMALIAN CELL CULTURE MEDIA FORMULATIONS |
| 04/06/2011 | EP2303912A1 Cdca1 epitope peptides and vaccines containing the same |
| 04/06/2011 | EP2303405A1 Apparatus and methods for controlling cellular development |
| 04/06/2011 | EP2303322A1 Recombinant modified vaccinia virus measles vaccine |